|
A new biflavonoid
from Selaginella uncinata (Desv.) Spring
Lei
Ting1, Jiang Haiyan2, Chi Cuiyun1, Wu Sichao3,
Cen Yinzhou1
(1 Department of Chemistry, Jinan University, Guangzhou 510632,
China; 2Guangdong Province Material Testing Center,
Guangzhou 510632, China; 3Integrated¡¡Technical¡¡Service Center Of
Guangzhou Entry-exit Inspection And Quarantine, Guangzhou
510632, China)
Abstract A new
biflavonoid, 5,7,4',5''-tetrahydroxy-7''-metroxy-[3-O-4'''] biflavone along with four known biflavonoids and one known phenolic
acid was isolated from the herb of Selaginella uncinata(Desv.)
Spring. Their structures were elucidated by spectroscopic methods.
Keywords Selaginella uncinata£»5,7,4',5''-tetrahydroxy-7''-metroxy-[3-O-4'''] biflavone
1. INTRODUCTION
Selaginella uncinata (Desv.) Spring as a medicinal plant is used to
treat acute infectious jaundice hepatitis, cholecystitis, enteritis and so on. In previous investigations of the
plant, two kinds of chromone glycoside (uncinoside A and uncinoside B) have been
separated from S. uncinata , which have good anti-tumor and anti-viral activity[1].
Our preliminary study found that ethyl acetate extract exhibited
good anti-HSV-1 virus and Cox B3 virus activity [2]. Through
activity-guided fractionation, we isolated a new biflavonoid,
named 5,7,4',5''-tetrahydroxy-7''- metroxy-[3-O-4'''] biflavone(IV),
together with five known compounds£º7,4',7',4'''-
tetra-O-methylamento-flavone(I)[3]£¬7, 7'', 4'''-trim-O-methyl amentoflavone(II)[4]£¬7, 7''-di-O-methylamentoflavone(III)[4]£¬amentoflavone(V)[5],
shikimic acid(VI)[6], and all the structures of these compounds were elucidated by spectral analysis.
2. EXPERIMENTAL
The air dried aerial parts of S. uncinata (10kg) was extracted three times with
95% ethanol at room temperature. The combined EtOH extract
was evaporated in vacuo to afford a gummy residue (520g).
The extracts were suspended in water and successively partitioned with petroleum ether,
EtOAc and n-BuOH, respectively. The EtOAc extract (50g) was repeatedly subjected to column chromatography to yield compound Ito VI.
3. RESULTS AND DISCUSSION
Compound IV was obtained as yellow powder, its
molecular formula was established as C31H20O10 (m/z
552.1022, calculated 552.1051) by HRESIMS. The IR (KBr, n, cm-1) spectrum showed the bands at 3409
(hydroxyl group), 1656 (conjugated carbonyl group), 1603, 1500 (aromatic ring). The
1H NMR and 13C NMR signals of compound IV (Table 1) were very similar to those of delicaflavone except for
the existence of the one methoxyl signals [d 3.86(3H, s)] instead of
hydroxyl. All the above information suggested that compound IV was a
derivative of delicaflavone. The methoxyl position was determined by analyzing the
difference of proton signals between compound IV and delicaflavone [7], that is d value
of H-6'' shifted from d 6.38 to d 6.19, and d value of H-8''
shifted from d 6.75
to d 6.47, respectively. Which showed the methoxyl group was located at
C-7''. This was further confirmed by HMBC spectrum, in which the signals at dH
6.75 and 6.38 along with signals of methoxyl group at dH 3.86 displayed correlation to dC 165.74.
Therefore the structure of compound IVwas elucidated
as 5,7,4',5''-tetrahydroxy-7''- metroxy-[3-O-4'''] biflavone.
¡¡
Table 1 NMR spectral data for compound IV in
DMSO
NO. |
dH (ppm) |
dC (ppm) |
HMBC |
2 |
¡¡ |
157.52 |
¡¡ |
3 |
¡¡ |
132.14 |
¡¡ |
4 |
¡¡ |
176.45 |
¡¡ |
4a |
¡¡ |
104.62 |
¡¡ |
5 |
¡¡ |
161.66 |
¡¡ |
6 |
6.24(1H,
d, J=1.6Hz) |
99.43 |
165.10,
161.66, 104.62, 94.69 |
7 |
|
165.10 |
¡¡ |
8 |
6.54
(1H, d, J=1.6Hz) |
94.69 |
165.10,
157.27, 99.43 |
8a |
¡¡ |
157.27 |
¡¡ |
1 ' |
¡¡ |
120.18 |
¡¡ |
2 '/6' |
7.83
(2H, d, J=8.8Hz) |
130.66 |
157.52,
161.16, 130.66 |
3 '/5' |
6.89
(2H, d, J=8.8Hz) |
116.27 |
161.16,
120.18, 116.27 |
4 ' |
¡¡ |
161.16 |
¡¡ |
2 '' |
¡¡ |
163.82 |
¡¡ |
3 '' |
6.92(1H,
s) |
104.87 |
163.82,
182.46, 105.30 |
4 '' |
¡¡ |
182.46 |
¡¡ |
4a '' |
¡¡ |
105.30 |
¡¡ |
5 '' |
|
161.66 |
¡¡ |
6 '' |
6.38(1H,
d, J=1.6 Hz) |
98.39 |
165.74,
161.66, 105.30, 93.25 |
7 '' |
¡¡ |
165.74 |
¡¡ |
8 '' |
6.75(1H,
d, J=1.6Hz) |
93.25 |
165.74,
157.79, 98.39, 105.30 |
8a '' |
¡¡ |
157.79 |
¡¡ |
9 '' |
3.86(3H,
s) |
56.55 |
165.74 |
1 ''' |
¡¡ |
125.31 |
¡¡ |
2 '''/6''' |
8.02(2H,
d, J=8.8Hz) |
129.07 |
163.82,
160.14, 129.07 |
3 '''/5''' |
7.25(2H,
d, J=8.8Hz) |
116.27 |
160.14,
125.31, 116.14 |
4 ''' |
¡¡ |
160.14 |
¡¡ |
OH-5 |
12.22(br,
s) |
¡¡ |
|
OH-5 '' |
12.86(br,
s) |
¡¡ |
|
¡¡

Figure 1 HMBC
correlations of compound IV
ACKNOWLEDGMENT
This work was supported by the National
Natural Science Foundation of China (No. 20772047£¬20472024), Natural Science Foundation of Guangdong Province, China (039213£©
REFERRENCES
[1] Ma L Y, Ma S C, Wei F, et al.. Chem Pharm Bull (Tokyo)£¬2003£¬51(11):1264-1267.
[2] Jiang H Y, Wu S C, Zhu J J, et al.. Journal of Jinan
University (Natural Science Edition), 2008, 29(05): 500-504.
[3] Ilyas M, Seligmann O, Wagner H. Journal of Biosciences , 1977, 32C(3-4): 206-209.
[4] Gu Y L, Xu Y M, Fang, S D, et al.. Zhiwu Xuebao, 1990,
32(8): 631-636.
[5] Jiang Y, Qian Z M, Zhang T D, et al.. Linchan Huaxue Yu
Gongye, 2008, 28(6): 58-60. [6] Zhou C, Zhang R P, Pu X Y, et
al..Chinese Journal of Ethnomedicine and Ethnopharmacy 1999, 37: 114-115.
[7] Lie C L, Cheng J C. The Chinese Pharmaceutical Journal£¬2000£¬52£º211-218.
¡¡
|